Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio Protocol (BIO) vs Ethereum (ETH) Price & Performance

Bio ProtocolTrade
EthereumTrade

Price performance (Past 24H)

Key statistics

Bio Protocol vs Ethereum — how do they compare? Bio Protocol trades at Rp516.22 (market cap Rp1,15T, Rp264,79M 24h volume), while Ethereum trades at Rp32,205,572 (market cap Rp3.859,82T, Rp188,91T 24h volume). The key difference: Ethereum is far larger — about 3356.4× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Ethereum's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Ethereum for 102 Days on average.

BIOETH
Market Cap
Rp1,15TRp3.859,82T
Volume (24h)
Rp264,79MRp188,91T
Circulating Supply
2,2B / 3,3B BIO (68%)120,7M ETH
Typical Hold Time
16 Days102 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bio Protocol

Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.

Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.

Ethereum

Ethereum is trading at Rp32,041,050 with a market cap of Rp3.862,5T, showing bullish technical signals with strong moving average support and key indicators like ADX signaling strong trend momentum. The asset maintains neutral oscillators while RSI shows mixed signals. Recent news highlights Ethereum's ecosystem growth potential and institutional interest in tokenization.

Overall outlook remains positive with strong technical momentum and growing ecosystem adoption, though investors should monitor regulatory developments and the mixed RSI signals indicating potential short-term consolidation. Major opportunities include continued DeFi dominance and tokenization growth, while risks involve crypto-specific regulatory uncertainty and market volatility.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BIO
0% Buy100% Sell
Avg holding period · 16 Days
ETH
43% Buy57% Sell
Avg holding period · 102 Days

Top news

Latest headlines on both assets

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO

About Ethereum

A crypto asset designed for decentralized applications and deployment of smart contracts, which are created and operated without any fraud, interruption, control or interference from a third party. It is the second most valuable crypto asset after BTC.

Read more on ETH